An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Houlihan Lokey Announces Expiration of Tender Offer Period for Outstanding Shares of GCA Corporation
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Houlihan Lokey (NYSE:HLI) announced the expiration of its tender offer for GCA Corporation (TSE:2174) as of September 27, 2021. The offer, priced at ¥1,398 ($12.71) per share, resulted in approximately 90% of GCA's common stock being tendered. The acquisition is expected to settle on October 4, 2021, with financing from Houlihan Lokey's balance sheet. The firm is recognized as a leading advisor in M&A and restructuring.
Positive
Acquisition of GCA Corporation expected to strengthen Houlihan Lokey's market position.
90% of GCA's shares tendered demonstrates strong shareholder support for the acquisition.
Acquisition financed with cash from Houlihan Lokey’s own balance sheet, indicating financial stability.
Negative
None.
LOS ANGELES--(BUSINESS WIRE)--
Houlihan Lokey (NYSE:HLI), the global investment bank, today announced the expiration of the tender offer period, as of 4:00 p.m. JST on September 27, 2021, related to the acquisition of GCA Corporation (“GCA”) (TSE:2174) for ¥1,398 ($12.71) per share and a total cash purchase price of approximately ¥65.9 billion ($599.1 million), based on an assumed exchange rate of ¥110 per $1.
Shares and stock options representing approximately 90% of GCA’s common stock on a fully diluted basis were validly tendered in the tender offer.
Houlihan Lokey commenced the tender offer to acquire all outstanding shares of GCA for ¥1,380 ($12.55) per share in cash, in addition to all stock options of GCA (priced to net out applicable exercise prices), in Tokyo on August 4, 2021, and announced a new purchase price of ¥1,398 ($12.71) per share on September 9, 2021 (JST).
The tender offer is expected to settle beginning on October 4, 2021. Following settlement of the tender offer, it is expected that Houlihan Lokey will complete the acquisition of GCA through a second-step transaction at the same price. The transaction is being financed with cash on Houlihan Lokey’s balance sheet.
About Houlihan Lokey
Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is the No. 1 M&A advisor for the past six consecutive years in the U.S., the No. 1 global restructuring advisor for the past seven consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 20 years, all based on number of transactions and according to data provided by Refinitiv.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. You can identify these statements by our use of the words “assumes,” “believes,” “estimates,” “expects,” “guidance,” “intends,” “plans,” “projects,” and similar expressions that do not relate to historical matters. You should exercise caution in interpreting and relying on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors (including the significant effect that the COVID-19 pandemic has had on our business and is expected to continue to have on our business), which are, in some cases, beyond Houlihan Lokey’s control and could materially affect actual results, performance, or achievements. For a further description of such factors, you should read Houlihan Lokey’s filings with the Securities and Exchange Commission. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Houlihan Lokey does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
